Franz Hefti

Affiliations: 
Rinat, Bishkek, Chuy Province, Kyrgyzstan 
Google:
"Franz Hefti"
Mean distance: 14.51 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Goure WF, Krafft GA, Jerecic J, et al. (2014) Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimer's Research & Therapy. 6: 42
Hefti F, Goure WF, Jerecic J, et al. (2013) The case for soluble Aβ oligomers as a drug target in Alzheimer's disease. Trends in Pharmacological Sciences. 34: 261-6
Naylor MD, Karlawish JH, Arnold SE, et al. (2012) Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52
Choi SR, Schneider JA, Bennett DA, et al. (2012) Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Disease and Associated Disorders. 26: 8-16
Kablinger AS, Lindner MA, Casso S, et al. (2012) Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study. Journal of Psychopharmacology (Oxford, England). 26: 973-81
Virostko J, Henske J, Vinet L, et al. (2011) Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proceedings of the National Academy of Sciences of the United States of America. 108: 20719-24
Zha Z, Choi SR, Ploessl K, et al. (2011) Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). Journal of Medicinal Chemistry. 54: 8085-98
Lister-James J, Pontecorvo MJ, Clark C, et al. (2011) Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. Seminars in Nuclear Medicine. 41: 300-4
Clark CM, Schneider JA, Bedell BJ, et al. (2011) Use of florbetapir-PET for imaging beta-amyloid pathology. Jama. 305: 275-83
Hefti FF, Kung HF, Kilbourn MR, et al. (2010) 18F-AV-133: A selective VMAT2-binding radiopharmaceutical for PET imaging of dopaminergic neurons Pet Clinics. 5: 75-82
See more...